ZYMVOLVER
Financiado
Launching A Unified Cloud-Based Platform for Next Generation Protein Editing
Actually, global enzymes market is today €8.18 billion and forecasted to reach €17.5 billion by 2024, so a sector growing at a CARG +9.56% in a 7-year projection. Europe is a main contender with over 62% of the exports. However,...
Actually, global enzymes market is today €8.18 billion and forecasted to reach €17.5 billion by 2024, so a sector growing at a CARG +9.56% in a 7-year projection. Europe is a main contender with over 62% of the exports. However, most companies with dedicated software for protein engineering computational are found in North America (46.0%), followed by Europe (29.4%), Asia-Pacific (17.9%) and RoW (6.7%). The production of daily life products such as paper, textiles, food, feed, chemicals and pharmaceuticals consumes large amounts of resources, water and energy. Furthermore, it generates enormous amounts of waste with an adverse impact on our environment and quality of life. Many studies show that implementing enzymatic processes instead of conventional chemical catalysis contributes to a more sustainable industry, reducing global warming (OECD, 2009; European Commission, 2009).ZYMVOLVER is a computer-driven speciality management to protein producers and industrial manufacturers. It offers a computer-aided decision-making tool for the adoption of industrial enzymes in standard industrial processes. We have developed a tool that will allow the democratization of computer-aided protein engineering. We offer a state-of-the-art, accessible, all-in-one computational tool that customize proteins with a 90% accuracy in terms of substrate selectivity, far beyond competition. ZYMEVOLVER - is exclusively owned by Zymvol. Our cloud-based, cost-effective software allows us to design any industrial enzyme from scratch, saving 50% of time and enzyme developing costs.The founding of Zymvol Biomodeling SL has over 20 years of combined experience previously working at one of Europe’s most important supercomputers – Barcelona Supercomputing Centre, which has been a necessary infrastructure for protein editing. ZYMVOL won the first prize in the pitch competition for most promising industrial start-up of 2017 organized by IQS Tech Factory and Richi Social Entrepreneurs in Boston.
ver más
Duración del proyecto: 3 meses
Fecha Inicio: 2018-06-01
Fecha Fin: 2018-09-30
Fecha Fin: 2018-09-30
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2018-09-30
Presupuesto
El presupuesto total del proyecto asciende a
71K€
Líder del proyecto
ZYMVOL BIOMODELING
Otra investigación y desarrollo experimental en ciencias naturales y técnicas. actividades de programación informática
Perfil tecnológico
TRL
4-5
2M
Perfil tecnológico
TRL
4-5
2M